The likelihood of declining surgery was increased for American Indian, Alaska Native, or other patients, Asian or Pacific Islander patients, and Black patients compared with White patients. HealthDay ...

Imsidolimab is an investigational humanized IgG4 antibody that inhibits the function of the interleukin-36 receptor. Findings from two phase 3 trials showed skin clearance was achieved and maintained ...

Rapid procedure noninferior to standard procedure for successful initiation of extended-release naltrexone. HealthDay News — For patients with opioid use disorder (OUD), a rapid procedure (RP) is ...

Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5%. HealthDay News — Diagnostic targeted Botox injections have high positive predictive value for migraine ...

Tool included 19 variables and had good predictive accuracy, identifying those who did not qualify for palivizumab. HealthDay News — A personalized tool can predict infants at increased risk for ...

Dr Michael Ganio, ASHP’s Director of Pharmacy Practice and Quality, joins me to discuss the current drug shortage crisis, which has reached new levels.

Synthetic-based drugs such as fentanyl and methamphetamine pose the greatest risk to the US. The Drug Enforcement Administration (DEA) has released the 2024 National Drug Threat Assessment (NDTA), an ...

Individuals are being urged to immediately update the mobile app to version 2.7.1 or later. Tandem Diabetes Care, Inc. has released an update to the Apple iOS t:connect mobile app, used in conjunction ...

MDMA is currently classified as a Schedule I controlled substance with no accepted medical use. The Food and Drug Administration (FDA) announced several upcoming advisory committee meetings that will ...

Cost, finding a provider, and stigma are top barriers to receiving treatment. HealthDay News — Three-quarters of US adults believe mental health issues are identified and treated worse than physical ...

The Company is offering a dedicated support platform called Cycle Vita to provide individualized product support to patients. Ormalvi ™ (dichlorphenamide) has been made available by Cycle ...

Findings showed treatment with delpacibart etedesiran reversed disease progression in DM1 patients based on multiple functional measures. The Food and Drug Administration (FDA) has granted ...